Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?
- PMID: 27454762
- DOI: 10.1111/liv.13208
Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?
Comment on
-
A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.Liver Int. 2016 Aug;36(8):1206-12. doi: 10.1111/liv.13098. Epub 2016 Mar 23. Liver Int. 2016. PMID: 26910784
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
